<a href="https://laohu8.com/S/ABEOW">Abeona Therapeutics Inc.</a> Reduces Loan Interest Rate and Issues Warrants in Amended Agreement
Abeona Therapeutics Inc. has announced a significant amendment to its Loan and Security Agreement with Avenue Venture Opportunities Fund, L.P., and Avenue Venture Opportunities Fund II, L.P. The amendment, effective July 18, 2025, reduces the interest rate on the company's senior secured term loan from 13.5% to a fixed rate of 11.75% per annum. As part of the agreement, Abeona issued warrants to the lenders to purchase up to 16,474 shares of the company's common stock, with an exercise price set at $6.07 per share. These warrants, which expire on July 18, 2030, can be exercised at any time before the expiration date. The agreement also includes provisions for anti-dilution adjustments and allows for cashless exercise under specific conditions.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abeona Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-020227), on July 18, 2025, and is solely responsible for the information contained therein.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。